These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12600191)

  • 1. [Role of growth hormone in cardiovascular diseases].
    Twardowski R; Mandecki T; Mizia-Stec K; Szymański L; Jastrzebska-Maj E
    Pol Arch Med Wewn; 2002 Sep; 108(3):925-9. PubMed ID: 12600191
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucose intolerance due to diseases of the pituitary].
    Suzuki S
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():629-35. PubMed ID: 9513489
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
    Bondanelli M; Bonadonna S; Ambrosio MR; Doga M; Gola M; Onofri A; Zatelli MC; Giustina A; degli Uberti EC
    Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are cold exposure and reduction of growth hormone secretion in the elderly synergetic risk factors in cardiovascular diseases?
    Leppäluoto J
    Int J Circumpolar Health; 2000 Oct; 59(3-4):273-6. PubMed ID: 11209680
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular effects of growth hormone deficiency in adults].
    Rzytki P; Marek B; Kajdaniuk D; Kos-Kudła B; Ostrowska Z; Borgiel-Marek H; Janczewska-Kazek E; Niedziołka D; Wyrwas-Bełz U; Zeka G
    Pol Merkur Lekarski; 2002 Jul; 13(73):62-5. PubMed ID: 12362511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone deficiency in treated acromegaly.
    Mazziotti G; Marzullo P; Doga M; Aimaretti G; Giustina A
    Trends Endocrinol Metab; 2015 Jan; 26(1):11-21. PubMed ID: 25434492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abnormal lipid metabolism in acromegaly].
    Inoue T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():162-6. PubMed ID: 11347050
    [No Abstract]   [Full Text] [Related]  

  • 8. The neoplastic complications of acromegaly.
    Terzolo M; Daffara F; Reimondo G; Allasino B; Ventura M; Angeli A
    J Endocrinol Invest; 2003; 26(8 Suppl):32-4. PubMed ID: 15233209
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth hormone and cardiovascular disease: an area in rapid growth.
    Thomas AM; Berglund L
    J Clin Endocrinol Metab; 2001 May; 86(5):1871-3. PubMed ID: 11344174
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of somatotropin and androgens on pneumatization].
    PUSCHEL L; SCHLOSSHAUER B
    Arch Ohren Nasen Kehlkopfheilkd; 1955; 167(2-6):595-610; discussion, 616-7. PubMed ID: 13303292
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Bunderen CC; van Varsseveld NC; Heymans MW; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Eur J Endocrinol; 2014 Dec; 171(6):717-26. PubMed ID: 25227133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gigantism and acromegaly: report of a case and review of the literature.
    George AR; Deen M; Atkins F
    J Natl Med Assoc; 1983 Nov; 75(11):1104, 1106-7. PubMed ID: 6655714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.
    Sesmilo G; Fairfield WP; Katznelson L; Pulaski K; Freda PU; Bonert V; Dimaraki E; Stavrou S; Vance ML; Hayden D; Klibanski A
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1692-9. PubMed ID: 11932303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gigantism and acromegaly in Singapore.
    Gwee HM; Chua D; Cheah JS; Pin L
    Singapore Med J; 1981 Oct; 22(5):266-70. PubMed ID: 7344089
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cerebral gigantism].
    Hidalgo R; Villarroel M
    Rev Chil Pediatr; 1986; 57(2):171-4. PubMed ID: 3562952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Psycho-endocrinologic syndrome in a 10-year-old boy with gigantism].
    Bautsch A; Orzech R; Strycharski W
    Przegl Lek; 1967; 23(9):693-6. PubMed ID: 6075301
    [No Abstract]   [Full Text] [Related]  

  • 18. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of acromegaly and gigantism with depression.
    Avery TL
    Br J Psychiatry; 1973 May; 122(570):599-600. PubMed ID: 4717035
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly.
    Powlson AS; Gurnell M
    Neuroendocrinology; 2016; 103(1):75-85. PubMed ID: 26227953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.